DFX Intelligence
Private Credit Intelligence
The capital structure graph behind private markets. Who lent, to whom, under which sponsor, through which facility, how large the piece was, when it matures and what changed, with a filing behind every number. A BDC piece is that BDC's piece, a sum of pieces is a lower bound, and a sponsor is named with the evidence that names it.
Borrowers
72 borrower groups currently held
A borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.
| Borrower | Sponsor | BDCs | Principal held | On cost | Next maturity | First seen |
|---|---|---|---|---|---|---|
| Kona Buyer, LLC Healthcare & Pharmaceuticals | unattributed | 17 | at least $624M | 100c | Jun 27, 2027 | Dec 31, 2021 |
| Allied Benefit Systems Intermediate LLC Healthcare & Pharmaceuticals | unattributed | 13 | at least $297M | 100c | Oct 1, 2030 | Dec 31, 2022 |
| AEG Vision Healthcare & Pharmaceuticals | Riata Capital Group, LLC carried | 2 | at least $100M | 100c | Mar 27, 2027 | Jun 30, 2024 |
| Zelis Cost Management Buyer, Inc Healthcare & Pharmaceuticals | unattributed | 9 | at least $86.4M | 98c | Sep 1, 2029 | Dec 31, 2022 |
| Soliant Lower Intermediate, LLC Healthcare & Pharmaceuticals | unattributed | 9 | at least $83.7M | 74c | Jul 1, 2031 | Dec 31, 2023 |
| Ellkay, LLC Healthcare & Pharmaceuticals | unattributed | 7 | at least $71.3M | 97c | Sep 14, 2030 | Dec 31, 2021 |
| Bamboo Health Holdings, LLC Healthcare & Pharmaceuticals | unattributed | 6 | at least $64.8M | 100c | May 1, 2028 | Mar 31, 2024 |
| Paradigm Parent, LLC Healthcare & Pharmaceuticals | Impresa Management LLC carried | 6 | at least $61.9M | 95c | Apr 16, 2032 | Dec 31, 2021 |
| BCTO Bobsled Purchaser, Inc Healthcare & Pharmaceuticals | unattributed | 4 | at least $61.6M | 100c | Jan 16, 2033 | Dec 31, 2025 |
| SCP Eye Care HoldCo, LLC Healthcare & Pharmaceuticals | unattributed | 10 | at least $59.8M | 100c | Oct 5, 2029 | Dec 31, 2022 |
| Mamba Purchaser, Inc Healthcare & Pharmaceuticals | Charlesbank Capital Partners, LLC inferred | 7 | at least $59.5M | 100c | Oct 1, 2031 | Dec 31, 2021 |
| Specialty Pharma III, Inc Healthcare & Pharmaceuticals | unattributed | 10 | at least $57.3M | 100c | Dec 23, 2032 | Feb 29, 2024 |
| Celerion Buyer, Inc Healthcare & Pharmaceuticals | Court Square Capital carried | 13 | at least $52.5M | 100c | May 8, 2033 | Dec 31, 2022 |
| CRH Healthcare Purchaser, Inc Healthcare & Pharmaceuticals | Freeman Spogli & Co. carried | 6 | at least $45.7M | 106c | Sep 17, 2031 | Sep 30, 2021 |
| Waystar Technologies, Inc Healthcare & Pharmaceuticals | unattributed | 11 | at least $45.6M | 100c | Oct 1, 2029 | Dec 31, 2021 |
| Apollo Intelligence Healthcare & Pharmaceuticals | unattributed | 2 | at least $37.9M | 99c | Jun 1, 2028 | Sep 30, 2022 |
| Bianalisi S.p.A Healthcare & Pharmaceuticals | unattributed | 2 | at least $34.7M | 106c | Feb 26, 2032 | Mar 31, 2025 |
| Hoosier Intermediate, LLC Healthcare & Pharmaceuticals | unattributed | 3 | at least $31.6M | 101c | Nov 15, 2028 | Dec 31, 2021 |
| Bayside OPCP, LLC Healthcare & Pharmaceuticals | unattributed | 1 | at least $25.9M | 100c | May 31, 2027 | Jun 30, 2023 |
| USME Holdco LLC Healthcare & Pharmaceuticals | unattributed | 2 | at least $23.8M | 99c | May 26, 2031 | Jun 30, 2025 |
| RxB Holdings, Inc Healthcare & Pharmaceuticals | unattributed | 10 | at least $20.0M | 102c | Dec 23, 2030 | Dec 31, 2021 |
| EHE Health Healthcare & Pharmaceuticals | unattributed | 2 | at least $18.9M | 99c | Aug 7, 2030 | Sep 30, 2024 |
| Hermes BidCo Germany GmbH Healthcare & Pharmaceuticals | unattributed | 2 | at least $16.9M | 98c | Apr 29, 2033 | Jun 30, 2026 |
| Vienna Bidco Limited Healthcare & Pharmaceuticals | unattributed | 2 | at least $14.5M | 99c | Aug 20, 2030 | Sep 30, 2025 |
| Birsa S.p.A Healthcare & Pharmaceuticals | unattributed | 3 | at least $14.4M | 103c | Jun 30, 2031 | Sep 30, 2024 |
| Ethos Bidco, Ltd Healthcare & Pharmaceuticals | unattributed | 2 | at least $14.1M | 99c | Mar 12, 2033 | Mar 31, 2026 |
| Nuzoa Bidco Healthcare & Pharmaceuticals | unattributed | 2 | at least $13.3M | 99c | Jun 24, 2032 | Jun 30, 2025 |
| WSHP Cottonwood Buyer, LLC Healthcare & Pharmaceuticals | unattributed | 2 | at least $13.0M | 100c | Dec 20, 2032 | Dec 31, 2025 |
| Beacon Specialized Living Healthcare & Pharmaceuticals | unattributed | 2 | at least $11.9M | 101c | Mar 25, 2028 | Jun 30, 2024 |
| Great Expressions Dental Center PC Healthcare & Pharmaceuticals | unattributed | 1 | at least $10.0M | 85c | Sep 30, 2026 | Dec 31, 2021 |
| AArete Investment, LLC Healthcare & Pharmaceuticals | unattributed | 2 | at least $9.9M | 102c | Jun 5, 2031 | Jun 30, 2025 |
| Dane Street, LLC Healthcare & Pharmaceuticals | Quad-C Management, Inc. carried | 5 | at least $9.8M | 100c | Mar 24, 2033 | Dec 31, 2025 |
| Psychiatric Medical Care LLC Healthcare & Pharmaceuticals | unattributed | 2 | at least $9.5M | 100c | Jul 1, 2032 | Sep 30, 2025 |
| Accident Care Alliance Holdco LLC Healthcare & Pharmaceuticals | unattributed | 2 | at least $9.1M | 101c | Aug 20, 2030 | Sep 30, 2025 |
| Red Nucleus Healthcare & Pharmaceuticals | unattributed | 2 | at least $9.0M | 100c | Oct 17, 2031 | Dec 31, 2024 |
| AOM Infusion Healthcare & Pharmaceuticals | Revelstoke Capital Partners carried | 2 | at least $8.6M | 101c | Mar 19, 2032 | Mar 31, 2025 |
| Odyssey Healthcare & Pharmaceuticals | unattributed | 5 | at least $7.6M | 102c | Nov 21, 2030 | Dec 31, 2021 |
| RedMed Operations Healthcare & Pharmaceuticals | unattributed | 2 | at least $7.5M | 101c | Feb 28, 2031 | Mar 31, 2025 |
| Alldent Holding GmbH Healthcare & Pharmaceuticals | unattributed | 2 | at least $5.8M | 99c | Nov 29, 2032 | Dec 31, 2025 |
| Davita Inc Healthcare & Pharmaceuticals | unattributed | 3 | at least $5.5M | 100c | May 9, 2031 | Jun 30, 2024 |
| Genmab A Healthcare & Pharmaceuticals | unattributed | 3 | at least $5.0M | 100c | Dec 13, 2032 | Dec 31, 2025 |
| Mertus 522. GmbH Healthcare & Pharmaceuticals | unattributed | 2 | at least $4.6M | 101c | May 28, 2028 | Dec 31, 2021 |
| Pharmacy Partners Healthcare & Pharmaceuticals | unattributed | 3 | at least $3.8M | 100c | Feb 28, 2029 | Mar 31, 2024 |
| Nafinco Healthcare & Pharmaceuticals | unattributed | 2 | at least $3.4M | 106c | Aug 29, 2031 | Sep 30, 2024 |
| QPE Alpha 4 Pty Ltd Healthcare & Pharmaceuticals | unattributed | 2 | at least $3.2M | 99c | Feb 5, 2032 | Jun 30, 2026 |
| QPE Alpha 4 Pty Ltd ACN 664 132 530 Healthcare & Pharmaceuticals | unattributed | 2 | at least $3.2M | 98c | Feb 5, 2032 | Mar 31, 2026 |
| Western Dental Healthcare & Pharmaceuticals | Court Square Capital carried | 3 | at least $2.1M | 100c | Jan 30, 2032 | Dec 31, 2022 |
| WellSky Healthcare & Pharmaceuticals | unattributed | 3 | at least $2.0M | 100c | Mar 10, 2028 | Dec 31, 2022 |
| Soliant Healthcare & Pharmaceuticals | unattributed | 4 | at least $1.9M | 75c | Jul 18, 2031 | Dec 31, 2022 |
| McKesson Medical-Surgical Top Holdings Inc Healthcare & Pharmaceuticals | unattributed | 4 | at least $1.9M | 100c | Jun 9, 2032 | Jun 30, 2026 |
Page 1 of 2Next
Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.